STRAND AND ELAN PHARMACEUTICALS ENTER INTO RESEARCH COLLABORATION

Strand Life Sciences, a Bangalore-based in silico technologies company announced today that it has entered into a research collaboration with Elan Pharmaceuticals aimed towards supporting Elan's drug discovery efforts. This collaboration allows Elan to access Strand's technologies and achieve customized solutions for internal research programs. The agreement incorporates access to Strand's extensive in silico technology portfolio including predictive modeling for efficacy and ADMET, custom library design, QSAR and pharmacophore modeling, structure based drug design, data and visual mining and consulting experience.
Genetic Engineering News